NCT00276614View on ClinicalTrials.gov

Bortezomib in Treating Patients With Metastatic Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Kidney Cancer
Interventions
DRUG

bortezomib

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

Sponsors
All Listed Sponsors
collaborator

Millennium Pharmaceuticals, Inc.

INDUSTRY

lead

Jonsson Comprehensive Cancer Center

OTHER